Four miRNAs (miR-10b, miR-130b, miR-1304 and miR-302b) were highlighted as a marker for a high or low-risk of poor prognosis associated with the IDH1/2 mutations in lower-grade glioma patients [228]. The gene discussed is IDH1; the disease is central nervous system cancer.